Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 812

1.

[Female gender and pulmonary arterial hypertension: a complex relationship].

Manes A, Palazzini M, Dardi F, D'Adamo A, Rinaldi A, Galiè N.

G Ital Cardiol (Rome). 2012 Jun;13(6):448-60. doi: 10.1714/1073.11764. Italian.

PMID:
22622125
2.

[Congenital heart disease and acquired valvular lesions in pregnancy].

Horstkotte D, Fassbender D, Piper C.

Herz. 2003 May;28(3):227-39. Review. German.

PMID:
12756480
3.

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, Humbert M.

Am J Respir Crit Care Med. 2008 Jun 15;177(12):1377-83. doi: 10.1164/rccm.200712-1807OC. Epub 2008 Mar 20.

PMID:
18356561
4.
5.

[Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects].

Palazzini M, Manes A, Negro L, Marinelli A, Leci E, Gambetti S, Bachetti C, Beciani E, Conficoni E, Branzi A, Galiè N.

G Ital Cardiol (Rome). 2009 May;10(5):271-300. Review. Italian.

PMID:
19537440
6.

BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.

Liu D, Wu WH, Mao YM, Yuan P, Zhang R, Ju FL, Jing ZC.

Circ Cardiovasc Genet. 2012 Oct 1;5(5):511-8. doi: 10.1161/CIRCGENETICS.111.962209. Epub 2012 Aug 25.

7.

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.

Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jaïs X, Tregouet D, Reis A, Drouin-Garraud V, Fraisse A, Sitbon O, O'Callaghan DS, Simonneau G, Soubrier F, Humbert M.

Am J Respir Crit Care Med. 2010 Apr 15;181(8):851-61. doi: 10.1164/rccm.200908-1284OC. Epub 2010 Jan 7.

PMID:
20056902
8.

Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Galie N, Manes A, Palazzini M, Negro L, Marinelli A, Gambetti S, Mariucci E, Donti A, Branzi A, Picchio FM.

Drugs. 2008;68(8):1049-66. Review.

PMID:
18484798
9.

Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.

Kabata H, Satoh T, Kataoka M, Tamura Y, Ono T, Yamamoto M, Huqun, Hagiwara K, Fukuda K, Betsuyaku T, Asano K.

Respirology. 2013 Oct;18(7):1076-82. doi: 10.1111/resp.12117.

PMID:
23675998
10.

Prostanoids for pulmonary arterial hypertension.

Galiè N, Manes A, Branzi A.

Am J Respir Med. 2003;2(2):123-37. Review.

PMID:
14720012
11.

Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.

Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M.

Medicine (Baltimore). 2007 Sep;86(5):299-315. Review.

12.

Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

Machado RD, Aldred MA, James V, Harrison RE, Patel B, Schwalbe EC, Gruenig E, Janssen B, Koehler R, Seeger W, Eickelberg O, Olschewski H, Elliott CG, Glissmeyer E, Carlquist J, Kim M, Torbicki A, Fijalkowska A, Szewczyk G, Parma J, Abramowicz MJ, Galie N, Morisaki H, Kyotani S, Nakanishi N, Morisaki T, Humbert M, Simonneau G, Sitbon O, Soubrier F, Coulet F, Morrell NW, Trembath RC.

Hum Mutat. 2006 Feb;27(2):121-32.

PMID:
16429395
13.

[Clinical, haemodynamic and genetic features of familial pulmonary arterial hypertension].

Sztrymf B, Francoual J, Sitbon O, Labrune P, Jambou M, Poüs C, Simonneau G, Humbert M.

Rev Mal Respir. 2004 Nov;21(5 Pt 1):909-15. French.

PMID:
15622337
14.

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.

Pfarr N, Szamalek-Hoegel J, Fischer C, Hinderhofer K, Nagel C, Ehlken N, Tiede H, Olschewski H, Reichenberger F, Ghofrani AH, Seeger W, Grünig E.

Respir Res. 2011 Jul 29;12:99. doi: 10.1186/1465-9921-12-99.

15.

Pulmonary arterial hypertension in women.

Sanchez O, Marié E, Lerolle U, Wermert D, Israël-Biet D, Meyer G.

Rev Mal Respir. 2010 Oct;27(8):e79-87. doi: 10.1016/j.rmr.2009.12.001. Epub 2010 May 13. Review.

PMID:
20965396
16.

Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies.

Newman JH, Phillips JA 3rd, Loyd JE.

Ann Intern Med. 2008 Feb 19;148(4):278-83. Review.

PMID:
18283205
17.

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.

Girerd B, Montani D, Eyries M, Yaici A, Sztrymf B, Coulet F, Sitbon O, Simonneau G, Soubrier F, Humbert M.

Respir Res. 2010 Jun 10;11:73. doi: 10.1186/1465-9921-11-73.

18.
19.

Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.

Fujiwara M, Yagi H, Matsuoka R, Akimoto K, Furutani M, Imamura S, Uehara R, Nakayama T, Takao A, Nakazawa M, Saji T.

Circ J. 2008 Jan;72(1):127-33.

20.

Definition, classification, and epidemiology of pulmonary arterial hypertension.

Hoeper MM.

Semin Respir Crit Care Med. 2009 Aug;30(4):369-75. doi: 10.1055/s-0029-1233306. Epub 2009 Jul 24.

PMID:
19634076

Supplemental Content

Support Center